《中国医药生物技术》杂志
Home
|
News
|
About Journal
|
Editorial Board
|
Instruction
|
Subscriptions
|
Adv
|
Download
|
Contacts Us
|
Indexed-in
|
Rewarded
|
Chinese
2014
,
Vol. 9
Issue (3)
: 222-224
DOI
: 10.3969/cmba.j.issn.1673-713X.2014.03.012
Current Issue
|
Archive
|
Adv Search
|
Methodology comparison between pyrosequencing and Sanger sequencing assay in detecting CYP2C19*17 polymorphism
Abstract
Figure/Table
References
Related Citation (15)
Download:
PDF
(298 KB)
HTML
(1 KB)
Export:
BibTeX
|
EndNote
(RIS)
Received:
24 December 2013
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
WANG Qian
DU Ya-Mei
ZHANG Guo-Jun
KANG Xi-Xiong
Cite this article:
WANG Qian,DU Ya-Mei,ZHANG Guo-Jun, et al. Methodology comparison between pyrosequencing and Sanger sequencing assay in detecting CYP2C19*17 polymorphism[J]. , 2014, 9(3): 222-224.
URL:
http://www.cmbp.net.cn/EN/10.3969/cmba.j.issn.1673-713X.2014.03.012
OR
http://www.cmbp.net.cn/EN/Y2014/V9/I3/222
[1]
MIAO Zhe, LU Fu-Qiong, MA Bo, LIU Xin.
[J]. , 2019, 14(4): 361-365.
京ICP备12020205
Copyright © 2010 Chinese Medicinal Biotechnology
TEL:010-62135779 FAX:010-62115976 E-mail: cmbj01@126.com
Support by
Beijing Magtech Co.ltd
, E-mail:
support@magtech.com.cn